1.The patients' satisfaction following implant treatment.
Yoon Young HEO ; Seong Joo HEO ; Myung Woo CHANG ; Ji Man PARK
The Journal of Korean Academy of Prosthodontics 2008;46(6):569-576
STATEMENT OF PROBLEM: While patient-centered outcomes are usually not reported, these may represent major aspects of the implant success for the patient. Use of a well-designed patient survey form can be an invaluable asset to the implant practitioners. PURPOSE: The objective of this study was to investigate patient satisfaction after implant therapy by means of a questionnaire. MATERIAL AND METHODS: South Korean patients (n = 100), who visited the dental examination center of Soon Chun Hyang university hospital, were asked to fill out the satisfaction questionnaire regarding aspects of cost, comfort, esthetics, chewing, gingival health, food impaction, phonetic aspect, screw loosening, and general satisfaction. Responses to statements were given on the Likert response scale. Four experimental groups of patients were distinguished with various location (A1, A2, A3), year (B1, B2, B3), number of implant replacements (C1, C2, C3), and treatment cost (D1, D2, D3). The reliability of the response scales was measured by calculation of its internal consistency, expressed as Cronbach's alpha. The scales were distinguished by means of factor analysis method. Possible differences in scale scores among the groups were assessed by One-way ANOVA (alpha = 0.05). RESULTS: Patients responded to most of the statements with high satisfaction. But the mean scale score of statement about cost was low. After the verification of internal consistency and factor analysis, five components, e.g. general satisfaction, comfort, chewing efficiency, esthetics, and phonetic aspect were grouped together. These components could be explained with common meaning and the first factor was named as 'general satisfaction' . Differences in patient satisfaction on the scale with esthetics were present between patients who have been wearing the implant prosthesis less than three years and those more than seven years (B1 < B3). CONCLUSION: The patients were generally satisfied with the outcome of implant treatment. But the patients' major complaint was high cost and while the statistically significant difference was not shown, the satisfaction scale about food impaction and esthetics was low. So the continuing efforts to make improvements about these problems are needed for the implant practitioners.
Dental Implants
;
Esthetics
;
Factor Analysis, Statistical
;
Health Care Costs
;
Humans
;
Mastication
;
Patient Satisfaction
;
Prostheses and Implants
;
Surveys and Questionnaires
;
Weights and Measures
2.The Effect of Lubricant on the Viabillty of Bacillus Calmette-Guerin.
Man Woo HEO ; Ho Yeon SONG ; Nam Kyu LEE
Korean Journal of Urology 1998;39(7):651-655
PURPOSE: Intravesical instillation of bacillus Calmette-Guerin(BCG) is an established and effective therapy for the superficial bladder carcinoma. The viability of BCG is crucial for the induction of a local immune response as well as effective therapy of recurrent superfical bladder carcinoma. Lubricants are used to facilitate catheterization during intravesical instillation of BCG. Moreover bacteriostatic components contained in them have potential to reduce the viability of the BCG. To verify this assumption, inhibitory effect of four commercially available lubricants on the BCG growth was analyzed. MATERIALS AND METHOD: Four different lubricants and their components were co-incubated with Connaught strain BCG and the resultant growth of BCG was assessed. RESULTS: Significant impairment of BCG viability with lubricants was noted. Chlorhexidine digluconate which is the component of lubricant was considered as responsible for this inhibition. CONCLUSIONS: During intravesical BCG, lubricants might reduce the number of viable BCG in clinical use. For this reason, during intravesical immunotherapy with BCG small amounts of lubricants should be used for urethral catheterization and use of lubricant which does not contain bacteriostatic agent should be considered.
Administration, Intravesical
;
Bacillus*
;
Catheterization
;
Catheters
;
Chlorhexidine
;
Immunotherapy
;
Lubricants
;
Mycobacterium bovis
;
Thiram
;
Urinary Bladder
;
Urinary Catheterization
;
Urinary Catheters
3.A case of osteoma in right ovarian fibroma.
Dal Hyeok HEO ; Kyung Hee LEE ; Man Chul PARK ; Yong Woo LEE ; Seoung Wan CHAE ; Jin Hee SOHN
Korean Journal of Obstetrics and Gynecology 2001;44(6):1205-1208
Ovarian fibroma is one of the sex cord-stromal tumor, and accounts for about 5 percent of all ovarian tumors surgically removed. This tumor is almost always unilateral and appears to affect the left ovary more often (75%) than the right. Calcification is one of the secondary changes that can take place in a fibroma of ovary. The occurrence of ossification in these calcified fibromas is rare. We experienced a case of an ovarian calcified fibroma with ossification occurring in a 19 year old, unmarried woman with a brief review of literature.
Female
;
Fibroma*
;
Humans
;
Osteoma*
;
Ovary
;
Sex Cord-Gonadal Stromal Tumors
;
Single Person
;
Young Adult
4.A Case of Malacoplakia of the Prostate.
Kuk Hyun LEE ; Man Woo HEO ; Ki Hyuck MOON ; Dae Jung KIM ; Youn Soo JEON ; Nam Kyu LEE
Korean Journal of Urology 1998;39(5):510-512
Malacoplakia is an uncommon granulomatous inflammatory disease, which predomina- ntly affected the urinary tract, particularly the urinary bladder. The prostatic involve- ment of malacoplakia is extremely rare and may clinically mimic prostate cancer. A correct diagnosis of malacoplakia can be made by histopathologic findings characterized by accumulations of macrophages containing typical intracytoplasmic inclusions(Michael is-Gutmann bodies). We report a case of prostatic malacoplakia, which was incidentally found in prostate biopsy performed to confirm clinically suspected prostate cancer.
Biopsy
;
Diagnosis
;
Macrophages
;
Malacoplakia*
;
Prostate*
;
Prostatic Neoplasms
;
Urinary Bladder
;
Urinary Tract
5.A Case of Sparganosis in the Scrotum.
Man Woo HEO ; Eung Koo KIM ; Youn Soo JEON ; Nam Kyu LEE ; Young Ho PARK
Korean Journal of Urology 1996;37(9):1051-1053
Sparganosis is a parasitic infestation caused by the larval stage of Spirometra erinacei. Human infection results from ingestion of raw or undercooked flesh of any of the numerous intermediate hosts and from application of such flesh as poultices. Sparganosis have been reported from orbit and bulbar conjunctiva. But, urogenital infestation of Sparganum is rarely observed. We report an additional case of the sparganum infestation in the right scrotum.
Conjunctiva
;
Eating
;
Humans
;
Orbit
;
Scrotum*
;
Sparganosis*
;
Sparganum
;
Spirometra
6.An in vitro study of mesenchymal stem cell proliferation on titanium discs coated with rhTGF-β2/PLGA by electrospray.
Joohyung KIM ; Seong Kyun KIM ; Seong Joo HEO ; Jai Young KOAK ; Woo Sung LEE ; Joo Hee LEE ; Ji Man PARK
The Journal of Korean Academy of Prosthodontics 2016;54(2):120-125
PURPOSE: The purpose of this study is to identify the effect of mesenchymal stem cell proliferation on recombinant human transforming growth factor-beta (rhTGF-β2) / poly (D,L-lactide-co-glycolide) (PLGA) treated titanium discs by electrospray. MATERIALS AND METHODS: Anodized titanium surface coated with PLGA was used for a control group to compare anodized titanium surface coated with 125 ng/ml and 500 ng/ml rhTGF-β2 as test groups. Atomic force microscope (AFM) test was utilized to determine the difference in coating surface roughness, and field-emission scanning electron microscopy (FE-SEM) was taken to visualize even distribution of coating particles on titanium discs. The mesenchymal stem cell proliferation was tested by using MTT (3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyl-tetrazolium bromide) assay on 1st, 4th, 7th days. RESULTS: According to AFM results, there was no statistically significant difference in titanium discs treated with PLGA and with rhTGF-β2/PLGA (P>.05). MTT assay test results showed that there was statistically significant difference in mesenchymal stem cell proliferation on test groups compared to control groups at 7th day, and cell viability on discs coated with rhTGF-β2 was significantly higher than control groups (P<.05). CONCLUSION: Titanium surface coated with rhTGF-β2/PLGA shows statistically significant higher cell proliferation and the titanium surface coated with the higher concentration of rhTGF-β2 presents faster cell growth activity.
Cell Proliferation
;
Cell Survival
;
Humans
;
Mesenchymal Stromal Cells*
;
Microscopy, Electron, Scanning
;
Titanium*
7.Osseointegration of the titanium implant coated with rhTGF-beta2/PLGA particles by electrospray: a preliminary microCT analyzing rabbit study.
Woo Sung LEE ; Seong Kyun KIM ; Seong Joo HEO ; Jai Young KOAK ; Joo Hee LEE ; Ji Man PARK ; Yoon Kyung PARK
The Journal of Korean Academy of Prosthodontics 2014;52(4):298-304
PURPOSE: This preliminary rabbit study was conducted to evaluate the effect of recombinant human transforming growth factor-beta2 (rhTGF-beta2)/poly lactic-co-glycolic acid (PLGA) coating on osseointegration of the titanium (Ti) implant. MATERIALS AND METHODS: Eight Ti implants were anodized with 300 voltages for three minutes. Four of those were coated with rhTGF-beta2/PLGA by an electrospray method as the experimental group. The implants were placed into tibiae of four New Zealand rabbits, two implants per a tibia, one implant per each group. After 3 and 6 weeks, every two rabbits were sacrificed and micro-computed tomography (microCT) was taken for histomorphometric analysis. RESULTS: In scanning electron microscope (SEM) image, the surface of rhTGF-beta2/PLGA coated Ti implant showed well distributed particles. Although statistically insignificant, microCT analysis showed that experimental group has higher bone volume / total volume (BV/TV) and trabecular thickness (Tb.Th) values relatively. Cross sectional view also showed more newly formed bone in the experimental group. CONCLUSION: In the limitation of this study, rhTGF-beta2/PLGA particles coating on the Ti implant show the possibility of more favorable quantity of newly formed bone after implant installation.
Humans
;
Osseointegration*
;
Rabbits
;
Tibia
;
Titanium*
;
Transforming Growth Factor beta2
;
X-Ray Microtomography*
8.A Case of Pelvic Actinomycosis Associated with Intrauterine Device.
Dal Hyeok HEO ; Ho Young KIM ; Kyung Hee LEE ; Man Chul PARK ; Yong Woo LEE ; Seoung Wan CHAE ; Jin Hee SOHN
Korean Journal of Obstetrics and Gynecology 2002;45(5):869-872
Pelvic actinomycosis is a rare disease and has diverse clinical manifestations and courses which make it difficult to diagnose the disease initially. Therefore the disease is still often diagnosed first at a laparotomy for a suspected malignant tumor. Since Henderson`s report (1973), the association between pelvic actinomycosis and intrauterine device has been recognized by gynecologists. IUD is thought to cause chronic intrauterine infection, tissue injury, and act as nucleus for parasitic infection. We report a case of Pelvic Actinomycosis related to IUD with brief review of concerned literatures.
Actinomycosis*
;
Intrauterine Devices*
;
Laparotomy
;
Rare Diseases
9.A Case of Acute Myocardial Infarction In Man Treated with Chemotherapy containing Doxorubicin for Non-Hodgkin Lymphoma..
Kyung Ho KIM ; Woo Jung PARK ; Taek Man NAM ; Duck Hyoung YOON ; Pil Seog HEO ; Young Choel DOO ; Kyu Rook HAN ; Dong Jin OH ; Kyu Hyeung YOO ; Jong Yoon LIM ; Kwang Hak LEE ; Young LEE
Korean Circulation Journal 2001;31(5):507-511
Anthracyclines have been widely used in cancer therapy because of their efficacy in the treatment of various solid tumors and hem -atologic malignancy. Cumulative dose-related cardiotoxicity was a well-known toxicity of anthracyclines. Particularly, at total doses of more than 550 mg/m2, therapy with anthracyclines could produce irreversible cardiac injury. Anthracycline-induced cardiac toxicity was usually manifested by congestive heart failure or arrhythmia. In co- ntrast, acute myocardial infarction is a rare event of anthracycline-induced heart diseases. A 31-year-old man with non-Hodgkin lymphoma(NHL) and single cardiac risk factor, including smoking, was presented with chest pain after receiving 2nd CEOP-BLAM chemo-therapy. An electrocardiogram revealed ST segment elevation in inferior leads consistent with acute myocardial infarction. An echocardiogram revealed an ejection fraction of 60% and severe hypokinesia in inferior and anteroseptal wall. Three days later, coronary angiography revealed 50% of luminal stenosis of right coronary artery(RCA) and near total occlusion with large thrombi in m-RCA. After balloon angioplasty and stent insertion, the patient was transferred to coronary care unit and continuous intravenous heparin infusion was started. On the 10th days, the patient was discharged in good condition. Six months later, follow-up coronary angiography showed no significant lesion in right coronary artery. In a young man with NHL, we report an acute myocardial infarction after 2nd course of CEOP-BLAM chemotherapy with a review of relevant literatures.
Adult
;
Angioplasty, Balloon
;
Anthracyclines
;
Arrhythmias, Cardiac
;
Chest Pain
;
Constriction, Pathologic
;
Coronary Angiography
;
Coronary Care Units
;
Coronary Vessels
;
Doxorubicin*
;
Drug Therapy*
;
Electrocardiography
;
Follow-Up Studies
;
Heart Diseases
;
Heart Failure
;
Heparin
;
Humans
;
Hypokinesia
;
Lymphoma, Non-Hodgkin*
;
Myocardial Infarction*
;
Phenobarbital
;
Risk Factors
;
Smoke
;
Smoking
;
Stents
10.A Case of Acute Myocardial Infarction In Man Treated with Chemotherapy containing Doxorubicin for Non-Hodgkin Lymphoma..
Kyung Ho KIM ; Woo Jung PARK ; Taek Man NAM ; Duck Hyoung YOON ; Pil Seog HEO ; Young Choel DOO ; Kyu Rook HAN ; Dong Jin OH ; Kyu Hyeung YOO ; Jong Yoon LIM ; Kwang Hak LEE ; Young LEE
Korean Circulation Journal 2001;31(5):507-511
Anthracyclines have been widely used in cancer therapy because of their efficacy in the treatment of various solid tumors and hem -atologic malignancy. Cumulative dose-related cardiotoxicity was a well-known toxicity of anthracyclines. Particularly, at total doses of more than 550 mg/m2, therapy with anthracyclines could produce irreversible cardiac injury. Anthracycline-induced cardiac toxicity was usually manifested by congestive heart failure or arrhythmia. In co- ntrast, acute myocardial infarction is a rare event of anthracycline-induced heart diseases. A 31-year-old man with non-Hodgkin lymphoma(NHL) and single cardiac risk factor, including smoking, was presented with chest pain after receiving 2nd CEOP-BLAM chemo-therapy. An electrocardiogram revealed ST segment elevation in inferior leads consistent with acute myocardial infarction. An echocardiogram revealed an ejection fraction of 60% and severe hypokinesia in inferior and anteroseptal wall. Three days later, coronary angiography revealed 50% of luminal stenosis of right coronary artery(RCA) and near total occlusion with large thrombi in m-RCA. After balloon angioplasty and stent insertion, the patient was transferred to coronary care unit and continuous intravenous heparin infusion was started. On the 10th days, the patient was discharged in good condition. Six months later, follow-up coronary angiography showed no significant lesion in right coronary artery. In a young man with NHL, we report an acute myocardial infarction after 2nd course of CEOP-BLAM chemotherapy with a review of relevant literatures.
Adult
;
Angioplasty, Balloon
;
Anthracyclines
;
Arrhythmias, Cardiac
;
Chest Pain
;
Constriction, Pathologic
;
Coronary Angiography
;
Coronary Care Units
;
Coronary Vessels
;
Doxorubicin*
;
Drug Therapy*
;
Electrocardiography
;
Follow-Up Studies
;
Heart Diseases
;
Heart Failure
;
Heparin
;
Humans
;
Hypokinesia
;
Lymphoma, Non-Hodgkin*
;
Myocardial Infarction*
;
Phenobarbital
;
Risk Factors
;
Smoke
;
Smoking
;
Stents